Research progress in targeted therapy for gastric cancer

Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 2

Abstract

Gastric cancer is a common malignant tumor worldwide, and its incidence rate and mortality have always been in the forefront. Most gastric cancer patients in China are diagnosed in the middle or late stages, with an unsatisfactory 5- year survival rate and poor prognosis. Prior to the emergence of targeted therapy, the combination chemotherapy of fluorouracil and platinum based drugs was considered a first- line treatment option, but the clinical benefits were limited. Targeted therapy, as a current research hotspot and new treatment method in the field of cancer treatment, has been proven by practice, clinical trials, and basic research to significantly improve the survival rate of gastric cancer patients, especially those in the middle and late stages. This article introduces the latest research progress in targeted therapy for gastric cancer, including human epidermal growth factor receptor- 2 (HER2), epidermal growth factor receptor (EGFR), fibroblast growth factor receptor (FGFR), etc., aiming to provide new ideas and directions for targeted therapy for gastric cancer.

Authors and Affiliations

WU Tengfei*, ZHAO Jinjin, LIN Jianxiu, TIAN Yun

Keywords

Related Articles

Effect and clinical efficacy of Ginkgo biloba tablets on fibroblast growth factor 4 in patients with unstable angina pectoris

Objective To explore the therapeutic effect of Ginkgo biloba tablets on patients with unstable angina and their impact on fibroblast growth factor 4 (FGF-4). Methods From January 2022 to September 2023, 360 patients with...

Influence of comprehensive intervention transtheoretical models on negative emotions and disease uncertainty of breast cancer patients undergoing chemotherapy

Objective To implement comprehensive intervention of transtheoretical model (TTM) for breast cancer patients with chemotherapy, and explore its impact on negative emotions and disease uncertainty. Methods Eighty-seven br...

Prognosis of 111 young patients with hypertensive intracerebral hemorrhage: a single center clinical study

<b>Objective</b> To explore the differences in prognosis of young hypertensive intracerebral hemorrhage (HIH) patients with different age, gender, and bleeding sites. <b>Methods</b> A retrospective analysis of 111 young...

Comparison of the efficacy and safety of programmed cell death protein 1 inhibitors combined with albumin-paclitaxel with or without platinum in the treatment of advanced metastasis or recurrent cervical cancer

<b>Objective</b> To compare the efficacy and safety of programmed cell death protein 1 (PD-1) inhibitor + albumin paclitaxel and platinum + PD-1 inhibitor + albumin-paclitaxel in the treatment of advanced metastasis or r...

Risk factors associated with severe coronavirus disease 2019 in maintenance hemodialysis patients

<b>Objective</b> To analyze the risk factors of severe coronavirus disease 2019 (COVID-19) in maintenance hemodialysis patients, and provide reference for early risk identification of the patients. <b>Methods</b> The...

Download PDF file
  • EP ID EP736505
  • DOI 10. 13429/j.cnki.cjcr.2024.02.001
  • Views 50
  • Downloads 0

How To Cite

WU Tengfei*, ZHAO Jinjin, LIN Jianxiu, TIAN Yun (2024). Research progress in targeted therapy for gastric cancer. Chinese Journal of Clinical Research, 37(2), -. https://europub.co.uk./articles/-A-736505